Lv3
260 积分 2023-11-01 加入
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
4天前
已完结
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
4天前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
4天前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
4天前
已完结
O7 Dupilumab – report of resolution of refractory eosinophilic oesophagitis alongside successful treatment of atopic eczema
6天前
已完结
Efficacy and safety of dupilumab in chronic hand eczema: a systematic review
6天前
已完结
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network
6天前
已完结
Association of risk of incident acne and treatment with systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and meta-analysis
6天前
已完结
Artificial Intelligence–Enabled Wearable Devices and Nocturnal Scratching in Mild Atopic Dermatitis
4个月前
已完结
Association of atopic dermatitis with conjunctivitis and other ocular surface diseases: A bidirectional two‐sample Mendelian randomization study
8个月前
已完结
皖公网安备34019202002308
